To date, emerging evidence has demonstrated that ADH1B-associated signaling pathways are key factors for tumorigenesis and progression, including esophageal squamous cell cancer (ESCC) (Suo et al., 2019) and colorectal cancer (CRC) (Choi et al., 2021). This evidence concerns the gene ADH1B and esophageal squamous cell carcinoma.